Published peptide research references
Bivalirudin
Governed registry record
25 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Open the peptide evidence profile →Approved source records
Evaluation of a Bivalirudin Dosing and Monitoring Protocol in Pediatric Extracorporeal Membrane Oxygenation.
Layne M Smith, Francis L Casey Iii, Dhaval Chauhan, Christopher E Mascio, Margaret Mathewson, Jai Udassi · The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025
Preliminary insights into monitoring bivalirudin anticoagulation: A retrospective cohort study of aPTT versus a chromogenic anti-IIa assay.
Sean G Yates, Ravi Sarode, Markus Velten, Jennifer Thibodeau, Abe DeAnda, Ibrahim F Ibrahim, Lisa Skariah · Journal of clinical anesthesia · 2025
Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation.
Ali McMichael, Jamie Weller, Xilong Li, Laura Hatton, Ayesha Zia, Lakshmi Raman · Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2025
Bivalirudin versus unfractionated heparin in patients with myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials.
Ahmad Al-Abdouh, Mohammed Mhanna, Ahmad Jabri, Luai Madanat, Laith Alhuneafat, Mostafa Reda Mostafa, Amartya Kundu, Vedant Gupta · Cardiovascular revascularization medicine : including molecular interventions · 2024
Effect of bivalirudin on coagulation in neonatal (cord) and adult human blood in vitro.
Sergiy M Nadtochiy, Tatsiana Stefanos, Richard Wissler, Yang Gu, Changyong Feng, Natalie Lebedko, Michael P Eaton · Paediatric anaesthesia · 2024
Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.
Behnood Bikdeli, David Erlinge, Marco Valgimigli, Adnan Kastrati, Yaling Han, Philippe Gabriel Steg, Rod H Stables, Roxana Mehran, Stefan K James, Enrico Frigoli, Patrick Goldstein, Yi Li · Circulation · 2023
Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.
Daochao Huang, QiongChan Guan, Jie Qin, Renfei Shan, Jinhong Wu, Chuang Zhang · Perfusion · 2023
Chromogenic and Clot-Based Bivalirudin Assays for Monitoring Anticoagulation.
Prashant Raghavendran, Benjamin F Tillman, Allison P Wheeler, David Gailani · The journal of applied laboratory medicine · 2023
Comparison of Bivalirudin Versus Heparin for Anticoagulation During Extracorporeal Membrane Oxygenation.
Daisuke Hasegawa, Ryota Sato, Narut Prasitlumkum, Kazuki Nishida, Brian Keaton, Samuel O Acquah, Young Im Lee · ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2023
Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review.
Carlos A Valdes, Omar M Sharaf, Mark S Bleiweis, Jeffrey P Jacobs, Mohammed Mumtaz, Ramy M Sharaf, Eric I Jeng, Giles J Peek · Frontiers in medicine · 2023
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
Yi Li, Zhenyang Liang, Lei Qin, Mian Wang, Xianzhao Wang, Huanyi Zhang, Yin Liu, Yan Li, Zhisheng Jia, Limin Liu, Hongyan Zhang, Jun Luo · Lancet (London, England) · 2022
Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.
Di-Huan Li, Ming-Wei Sun, Jian-Cheng Zhang, Chi Zhang, Lei Deng, Hua Jiang · Thrombosis research · 2022
Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.
Babikir Kheiri, Sunil V Rao, Mohammed Osman, Timothy F Simpson, Mahmoud Barbarawi, Yazan Zayed, Harsukh N Dhillon, Mohamad Alkhouli, Harsh Golwala, Firas Zahr, Deepak L Bhatt, Gregg W Stone · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2020
Bivalirudin with a post-procedure infusion versus heparin monotherapy for the prevention of stent thrombosis.
Rahman Shah, Samuel B Latham, Jennifer M Porta, Arshi Naz, Khalid Matin, Sunil V Rao · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2019
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.
Giuseppe Gargiulo, Greta Carrara, Enrico Frigoli, Sergio Leonardi, Pascal Vranckx, Gianluca Campo, Ferdinando Varbella, Paolo Calabrò, Tiziana Zaro, Davide Bartolini, Carlo Briguori, Giuseppe Andò · Journal of the American College of Cardiology · 2019
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes.
Giuseppe Gargiulo, Greta Carrara, Enrico Frigoli, Pascal Vranckx, Sergio Leonardi, Nestor Ciociano, Gianluca Campo, Ferdinando Varbella, Paolo Calabrò, Stefano Garducci, Alessandro Iannone, Carlo Briguori · Journal of the American College of Cardiology · 2018
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.
Marco Valgimigli, Enrico Frigoli, Sergio Leonardi, Martina Rothenbühler, Andrea Gagnor, Paolo Calabrò, Stefano Garducci, Paolo Rubartelli, Carlo Briguori, Giuseppe Andò, Alessandra Repetto, Ugo Limbruno · The New England journal of medicine · 2015
Critical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
Anthony A Bavry, Islam Y Elgendy, Ahmed Mahmoud, Manoj P Jadhav, Tianyao Huo · PloS one · 2015
Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.
Adeel Shahzad, Ian Kemp, Christine Mars, Keith Wilson, Claire Roome, Rob Cooper, Mohammed Andron, Clare Appleby, Mike Fisher, Aleem Khand, Babu Kunadian, Joseph D Mills · Lancet (London, England) · 2014
Bivalirudin started during emergency transport for primary PCI.
Philippe Gabriel Steg, Arnoud van 't Hof, Christian W Hamm, Peter Clemmensen, Frédéric Lapostolle, Pierre Coste, Jurrien Ten Berg, Pierre Van Grunsven, Gerrit Jan Eggink, Lutz Nibbe, Uwe Zeymer, Marco Campo dell' Orto · The New England journal of medicine · 2013
Pediatric catheterization laboratory anticoagulation with bivalirudin.
Thomas J Forbes, Ziyad M Hijazi, Guy Young, Jeremy M Ringewald, Paolo M Aquino, Robert N Vincent, Athar M Qureshi, Jonathan J Rome, John F Rhodes, Thomas K Jones, William B Moskowitz, Ralf J Holzer · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2011
Bivalirudin during primary PCI in acute myocardial infarction.
Gregg W Stone, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z Peruga, Bruce R Brodie, Dariusz Dudek, Ran Kornowski, Franz Hartmann, Bernard J Gersh, Stuart J Pocock, George Dangas, S Chiu Wong · The New England journal of medicine · 2008
Bivalirudin for patients with acute coronary syndromes.
Gregg W Stone, Brent T McLaurin, David A Cox, Michel E Bertrand, A Michael Lincoff, Jeffrey W Moses, Harvey D White, Stuart J Pocock, James H Ware, Frederick Feit, Antonio Colombo, Philip E Aylward · The New England journal of medicine · 2006
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.
A Michael Lincoff, John A Bittl, Robert A Harrington, Frederick Feit, Neal S Kleiman, J Daniel Jackman, Ian J Sarembock, David J Cohen, Douglas Spriggs, Ramin Ebrahimi, Gadi Keren, Jeffrey Carr · JAMA · 2003
Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.
J A Bittl, W H Ahmed · The American journal of cardiology · 1998